Clinical Trial Update: Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain [Phase 4]

View source ↗

Summary

A Phase 4 study reports on the tolerability of switching patients with painful diabetic neuropathy to duloxetine for pain management; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Neuropathy

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetic Neuropathy, Painful | Phase 4 | Status: COMPLETED